BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 20356845)

  • 21. Negative Regulation of Kruppel-Like Factor 4 on microRNA-106a at Upstream Transcriptional Level and the Role in Gastric Cancer Metastasis.
    Zhu M; Zhang N; Lu X; He S
    Dig Dis Sci; 2018 Oct; 63(10):2604-2616. PubMed ID: 29948558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
    Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
    Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8).
    Tiwari N; Meyer-Schaller N; Arnold P; Antoniadis H; Pachkov M; van Nimwegen E; Christofori G
    PLoS One; 2013; 8(2):e57329. PubMed ID: 23451207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.
    Chao YL; Shepard CR; Wells A
    Mol Cancer; 2010 Jul; 9():179. PubMed ID: 20609236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2 expression is related to the epithelial-to-mesenchymal transition in human colon cancers.
    Jang TJ; Jeon KH; Jung KH
    Yonsei Med J; 2009 Dec; 50(6):818-24. PubMed ID: 20046424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells.
    Bambang IF; Xu S; Zhou J; Salto-Tellez M; Sethi SK; Zhang D
    Lab Invest; 2009 Nov; 89(11):1229-42. PubMed ID: 19770839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.
    Yan W; Cao QJ; Arenas RB; Bentley B; Shao R
    J Biol Chem; 2010 Apr; 285(18):14042-51. PubMed ID: 20189993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha.
    Akaogi K; Nakajima Y; Ito I; Kawasaki S; Oie SH; Murayama A; Kimura K; Yanagisawa J
    Oncogene; 2009 Aug; 28(32):2894-902. PubMed ID: 19503094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.
    Bjerke GA; Hyman-Walsh C; Wotton D
    Mol Cell Biol; 2011 Sep; 31(18):3723-33. PubMed ID: 21746878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid Zinc Finger 1 (MZF1) Maintains the Mesenchymal Phenotype by Down-regulating IGF1R/p38 MAPK/ERα Signaling Pathway in High-level MZF1-expressing TNBC cells.
    Yue CH; Liu JY; Chi CS; Hu CW; Tan KT; Huang FM; Pan YR; Lin KI; Lee CJ
    Anticancer Res; 2019 Aug; 39(8):4149-4164. PubMed ID: 31366500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
    Hsu YM; Chen YF; Chou CY; Tang MJ; Chen JH; Wilkins RJ; Ellory JC; Shen MR
    Cancer Res; 2007 Nov; 67(22):11064-73. PubMed ID: 18006853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K-ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug.
    Khan P; Manna A; Saha S; Mohanty S; Mukherjee S; Mazumdar M; Guha D; Das T
    BMC Cancer; 2016 Jan; 16():39. PubMed ID: 26810856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity.
    Xue Y; Jia X; Li C; Zhang K; Li L; Wu J; Yuan J; Li Q
    Cell Death Dis; 2019 Oct; 10(11):814. PubMed ID: 31653828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
    Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
    J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.
    Na TY; Schecterson L; Mendonsa AM; Gumbiner BM
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5931-5937. PubMed ID: 32127478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Ca
    Dang DK; Makena MR; Llongueras JP; Prasad H; Ko M; Bandral M; Rao R
    Mol Cancer Res; 2019 Aug; 17(8):1735-1747. PubMed ID: 31076498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Krüppel-like Factor 4-p21
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2019 Mar; 12(3):125-134. PubMed ID: 30723175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-103 Promotes Proliferation and Metastasis by Targeting KLF4 in Gastric Cancer.
    Zheng J; Liu Y; Qiao Y; Zhang L; Lu S
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28445396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.